|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/235 | |
| A61K 31/422 | |||
| A61K 31/435 | |||
| A61K 31/517 | |||
| A61K 38/10 | |||
| A61K 45/06 | |||
| A61P 7/02 | |||
| A61P 7/00 | |||
| A61K 31/44 | |||
| A61K 31/5377 | |||
| A61K 31/496 | |||
| A61K 31/4439 | |||
| A61K 31/445 | |||
| A61K 31/40 |
| (11) | Number of the document | 2146705 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08747590.1 |
| Date of filing the European patent application | 2008-05-02 | |
| (97) | Date of publication of the European application | 2010-01-27 |
| (45) | Date of publication and mention of the grant of the patent | 2014-03-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/062561 |
| Date | 2008-05-02 |
| (87) | Number | WO 2008/137787 |
| Date | 2008-11-13 |
| (30) | Number | Date | Country code |
| 915649 P | 2007-05-02 | US | |
| 915911 P | 2007-05-03 | US | |
| 947921 P | 2007-07-03 | US | |
| 978700 P | 2007-10-09 | US |
| (72) |
CONLEY, Pamela B., US
ANDRE, Patrick, US
SINHA, Uma, US
|
| (73) |
Portola Pharmaceuticals, Inc.,
270 East Grand Avenue Suite 22, South San Francisco California 94080,
US
|
| (54) | COMBINATION THERAPY WITH A COMPOUND ACTING AS A PLATELET ADP RECEPTOR INHIBITOR |
| COMBINATION THERAPY WITH A COMPOUND ACTING AS A PLATELET ADP RECEPTOR INHIBITOR |